Moreover, conjugation of EVs with the KIM-1 targeting antibody has been shown to enhance the retention of exogenously administered EVs in the kidney and endowed with increased therapeutic anti-inflammatory properties in murine renal artery stenosis [63]. This evidence concerns the gene HAVCR1 and Renal artery stenosis.